Faller, Nicolas

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2022 | 2019 | 2018

2023

Bargagli, Matteo; Vetsch, Andri; Anderegg, Manuel A; Dhayat, Nasser A; Huynh-Do, Uyen; Faller, Nicolas; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G (2023). Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients. Nephrology, dialysis, transplantation, 38(7), pp. 1645-1654. Oxford University Press 10.1093/ndt/gfac298

Ferraro, Pietro Manuel; Bargagli, Matteo; Faller, Nicolas; Anderegg, Manuel A; Huynh-Do, Uyen; Vogt, Bruno; Gambaro, Giovanni; Fuster, Daniel G (2023). The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease. Journal of nephrology JN, 36(4), pp. 1011-1018. Wichtig Editore 10.1007/s40620-022-01540-5

Dhayat, Nasser A; Bonny, Olivier; Roth, Beat; Christe, Andreas; Ritter, Alexander; Mohebbi, Nilufar; Faller, Nicolas; Pellegrini, Lisa; Bedino, Giulia; Venzin, Reto M; Grosse, Philipp; Hüsler, Carina; Koneth, Irene; Bucher, Christian; Del Giorno, Rosaria; Gabutti, Luca; Mayr, Michael; Odermatt, Urs; Buchkremer, Florian; Ernandez, Thomas; ... (2023). Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England journal of medicine NEJM, 388(9), pp. 781-791. Massachusetts Medical Society MMS 10.1056/NEJMoa2209275

2022

Schietzel, Simeon; Bally, Lia; Cereghetti, Grazia; Faller, Nicolas; Moor, Matthias B; Vogt, Bruno; Rintelen, Felix; Trelle, S; Fuster, Daniel (2022). Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial. BMJ open, 12(3), e059073. BMJ Publishing Group 10.1136/bmjopen-2021-059073

2019

Faller, Nicolas; Dhayat, Nasser; Fuster, Daniel Guido (2019). Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules. Urolithiasis, 47(1), pp. 43-56. Springer 10.1007/s00240-018-1097-z

2018

Dhayat, Nasser; Faller, Nicolas; Rintelen, Felix; Roumet, Marie Camille; Irincheeva, Irina; Trelle, Sven; Tamò, Luca; Roth, Beat; Vogt, Bruno; Fuster, Daniel G (2018). Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC nephrology, 19(1), p. 349. BioMed Central 10.1186/s12882-018-1144-6

Provide Feedback